Fang lab

The Fang laboratory has broad interests and deep expertise in vascular biology, non-coding genome, and nano-medicine. We investigate the pathophysiological mechanisms of vascular diseases, particularly the modulation of vascular health by non-coding genome in the context of cardiovascular complication (atherosclerosis) and pulmonary disease (acute lung injury). Our major research goals are 1) to elucidate novel non-coding genome-mediated disease mechanisms and 2) to develop new nanomedicine-based diagnostic and therapeutic applications.